Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 An HIV vaccine--challenges and prospects.

Literature DB >> 18753644

An HIV vaccine--challenges and prospects.

Margaret I Johnston¹, Anthony S Fauci.

Abstract

Mesh：

Substances：
AIDS Vaccines
AIDSVAX

Year: 2008 PMID： 18753644 DOI： 10.1056/NEJMp0806162

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

47 in total

1. Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV.

Authors: Mark D Hicar; Xuemin Chen; Bryan Briney; Jason Hammonds; Jaang-Jiun Wang; Spyros Kalams; Paul W Spearman; James E Crowe
Journal: J Acquir Immune Defic Syndr Date: 2010-07 Impact factor: 3.731

2. The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise.

Authors:
Journal: Nat Med Date: 2010-09 Impact factor: 53.440

3. Infection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virus.

Authors: Rebecca L R Powell; Thompson Kinge; Phillipe N Nyambi
Journal: J Virol Date: 2010-07-14 Impact factor: 5.103

4. Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.

Authors: John B Schell; Nina F Rose; Kapil Bahl; Kathryn Diller; Linda Buonocore; Meredith Hunter; Preston A Marx; Ratish Gambhira; Haili Tang; David C Montefiori; Welkin E Johnson; John K Rose
Journal: J Virol Date: 2011-04-13 Impact factor: 5.103

Review 5. HIV vaccines: lessons learned and the way forward.

Authors: Jerome H Kim; Supachai Rerks-Ngarm; Jean-Louis Excler; Nelson L Michael
Journal: Curr Opin HIV AIDS Date: 2010-09 Impact factor: 4.283

6. Replication-defective adenovirus vectors with multiple deletions do not induce measurable vector-specific T cells in human trials.

Authors: Richard A Koup; Laurie Lamoreaux; David Zarkowsky; Robert T Bailer; C Richter King; Jason G D Gall; Douglas E Brough; Barney S Graham; Mario Roederer
Journal: J Virol Date: 2009-04-01 Impact factor: 5.103

An HIV vaccine--challenges and prospects.

1. Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV.

2. The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise.

3. Infection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virus.

4. Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.

Review 5. HIV vaccines: lessons learned and the way forward.

6. Replication-defective adenovirus vectors with multiple deletions do not induce measurable vector-specific T cells in human trials.

7. Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccine.

8. Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector.

9. Conceptualizing a Human Right to Prevention in Global HIV/AIDS Policy.

Review 10. Applications and challenges of multivalent recombinant vaccines.